SGX to allow SPACs to list in Singapore
SGX announced Thursday new rules to allow special purpose acquisition companies (SPACs) to list on the mainboard, effective Friday.
IPOs
Temasek-backed Shanghai NewMed Medical files for Hong Kong IPO
Shanghai NewMed Medical, a China-based heart-valve device company which counts Temasek as a backer, filed a prospectus Monday for an HK IPO.
UPDATE: Adani Wilmar IPO placed on hold by India’s regulators
The proposed IPO of Adani Wilmar, a 50:50 joint venture between the Adani Group and Wilmar, has been put on hold by the India’s SEBI.
UPDATE: Singapore stock briefs Monday: Wilmar, Mapletree Logistics, Nanofilm, Viking Offshore, Chip Eng Seng, Kangda, Yanlord
Singapore companies which may be in focus Monday, 23 Aug 2021: Mapletree Logistics, Nanofilm, Viking Offshore, Chip Eng Seng, China Kangda Food and Yanlord.
ComfortDelGro seeks Australia IPO for Australian subsidiary
ComfortDelGro is seeking an IPO on ASX for its subsidiary ComfortDelGro Corp. Australia (CDC), the taxi, bus and fleet operator said Monday.
Olam plans London IPO for Olam Food Ingredients
Olam said Friday it will seek a primary LSE listing for its operating group Olam Food Ingredients, while also seeking a Singapore listing.
HotelPlanner set to list on Nasdaq in SPAC deal valuing combined company at around US$567M
HotelPlanner is planning to merge with Reservations.com before combining with SPAC Astrea Acquisition for a listing on Nasdaq.
Golden Agri’s 56 percent-owned subsidiary Gemini Edibles files for India IPO
Golden Agri-Resources said Sunday its 56.27%-owned subsidiary, Gemini Edibles & Fats India, or GEF, has started the IPO process in India.
Adani Wilmar files draft prospectus for India IPO to raise up to US$600M
Adani Wilmar (AWL), a 50:50 joint venture between the Adani Group and Singapore-listed Wilmar, has filed a draft prospectus for an India IPO.
Trendlines won’t proceed with dual listing on Tel Aviv Stock Exchange
The Trendlines Group has decided not to proceed with its proposed dual listing and securities offer on the Tel Aviv Stock Exchange (TASE) in Israel, the Singapore-listed investor in medical and agricultural technology startups said in a filing to SGX Thursday.
Temasek-backed vaccine maker Jiangsu Recbio files for HK IPO
Temasek holds 2.68 percent of vaccine developer Jiangsu Recbio Technology, or 12 million pre-listing shares, according to the IPO prospectus.
Temasek’s nearly 38 percent of Intapp valued around US$618M
Temasek holds 22.13M shares of U.S.-listed Intapp, or a 37.7% stake, according to a filing to U.S. securities regulators Monday.